6-7121-901
SARS-CoV-2 peptide GYQPYRVVVL (HLA-A*2402)
Single peptide synthesized as presented by the MHC class I allele
SARS-CoV-2 peptide GYQPYRVVVL (HLA-A*2402) is a single peptide for stimulation of T cells. The peptide from SARS-CoV-2 is synthesized as it is presented by the MHC class I HLA-A*2402 allele and can be used for targeted in vitro generation and expansion of antigen-specific CD8+ T cells.
The peptides were purified by HPLC using a water and acetonitrile gradient and are endotoxin-free.
| Form: | Lyophilized powder |
|---|---|
| Peptide Sequence: | GYQPYRVVVL |
| Possible Application: | T cell stimulation |
| Purity: | > 85% |
| Sterility: | Sterile |
| MHC I Compatibility: | HLA-A*2402 |
| Storage: | -20 °C |
|---|---|
| Stability: | 12 months after shipping |
| Shipping: | Room temperature |
Related Products
CD8 Fab-TACS® Agarose Column Starter Kit, human
Label-free isolation of cytotoxic T cells from whole blood, buffy coat or PBMCs
CD8 Fab-TACS® Magnetic Microbead Starter Kit, human
Label-free isolation cytotoxic T cells from PBMCs
